vs

Side-by-side financial comparison of American Outdoor Brands, Inc. (AOUT) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $57.2M, roughly 1.5× American Outdoor Brands, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 3.6%, a 19.2% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -5.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-14.1M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 3.5%).

Deckers Outdoor Corporation, doing business as Deckers Brands, is an American footwear designer and distributor founded in 1973 and based in Goleta, California. The company's portfolio of brands includes UGG, Teva, and Hoka. It was founded by Doug Otto and Karl F. Lopker.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

AOUT vs FDMT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.5× larger
FDMT
$85.1M
$57.2M
AOUT
Growing faster (revenue YoY)
FDMT
FDMT
+8508905.0% gap
FDMT
8508900.0%
-5.0%
AOUT
Higher net margin
FDMT
FDMT
19.2% more per $
FDMT
22.8%
3.6%
AOUT
More free cash flow
FDMT
FDMT
$42.6M more FCF
FDMT
$28.5M
$-14.1M
AOUT
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
3.5%
AOUT

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AOUT
AOUT
FDMT
FDMT
Revenue
$57.2M
$85.1M
Net Profit
$2.1M
$19.4M
Gross Margin
45.6%
Operating Margin
3.7%
17.3%
Net Margin
3.6%
22.8%
Revenue YoY
-5.0%
8508900.0%
Net Profit YoY
-33.3%
139.1%
EPS (diluted)
$0.16
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AOUT
AOUT
FDMT
FDMT
Q4 25
$57.2M
$85.1M
Q3 25
$29.7M
$90.0K
Q2 25
$61.9M
$15.0K
Q1 25
$58.5M
$14.0K
Q4 24
$60.2M
$1.0K
Q3 24
$41.6M
$3.0K
Q2 24
$46.3M
$5.0K
Q1 24
$53.4M
$28.0K
Net Profit
AOUT
AOUT
FDMT
FDMT
Q4 25
$2.1M
$19.4M
Q3 25
$-6.8M
$-56.9M
Q2 25
$-992.0K
$-54.7M
Q1 25
$169.0K
$-48.0M
Q4 24
$3.1M
Q3 24
$-2.4M
$-43.8M
Q2 24
$-5.3M
$-35.0M
Q1 24
$-2.9M
$-32.4M
Gross Margin
AOUT
AOUT
FDMT
FDMT
Q4 25
45.6%
Q3 25
46.7%
Q2 25
40.9%
Q1 25
44.7%
Q4 24
48.0%
Q3 24
45.4%
Q2 24
41.9%
Q1 24
42.7%
Operating Margin
AOUT
AOUT
FDMT
FDMT
Q4 25
3.7%
17.3%
Q3 25
-23.0%
-67983.3%
Q2 25
-1.5%
-396373.3%
Q1 25
0.5%
-383007.1%
Q4 24
5.1%
Q3 24
-6.2%
-1704400.0%
Q2 24
-11.9%
-849120.0%
Q1 24
-5.4%
-136200.0%
Net Margin
AOUT
AOUT
FDMT
FDMT
Q4 25
3.6%
22.8%
Q3 25
-23.0%
-63195.6%
Q2 25
-1.6%
-364386.7%
Q1 25
0.3%
-342657.1%
Q4 24
5.2%
Q3 24
-5.7%
-1461433.3%
Q2 24
-11.5%
-699060.0%
Q1 24
-5.4%
-115717.9%
EPS (diluted)
AOUT
AOUT
FDMT
FDMT
Q4 25
$0.16
$0.43
Q3 25
$-0.54
$-1.01
Q2 25
$-0.08
$-0.98
Q1 25
$0.01
$-0.86
Q4 24
$0.24
Q3 24
$-0.18
$-0.79
Q2 24
$-0.41
$-0.63
Q1 24
$-0.23
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AOUT
AOUT
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$3.1M
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$170.4M
$505.7M
Total Assets
$240.9M
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AOUT
AOUT
FDMT
FDMT
Q4 25
$3.1M
$402.7M
Q3 25
$17.8M
$305.1M
Q2 25
$23.4M
$293.2M
Q1 25
$17.1M
$321.4M
Q4 24
$14.2M
$424.9M
Q3 24
$23.5M
$501.9M
Q2 24
$29.7M
$541.9M
Q1 24
$15.9M
$525.9M
Stockholders' Equity
AOUT
AOUT
FDMT
FDMT
Q4 25
$170.4M
$505.7M
Q3 25
$167.8M
$369.0M
Q2 25
$177.6M
$420.9M
Q1 25
$178.7M
$469.7M
Q4 24
$178.9M
$510.6M
Q3 24
$175.7M
$552.9M
Q2 24
$177.9M
$588.3M
Q1 24
$182.4M
$600.6M
Total Assets
AOUT
AOUT
FDMT
FDMT
Q4 25
$240.9M
$566.7M
Q3 25
$241.9M
$424.0M
Q2 25
$246.4M
$473.6M
Q1 25
$245.9M
$515.7M
Q4 24
$254.1M
$560.4M
Q3 24
$244.8M
$604.0M
Q2 24
$240.6M
$620.1M
Q1 24
$239.1M
$629.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AOUT
AOUT
FDMT
FDMT
Operating Cash FlowLast quarter
$-13.3M
$28.6M
Free Cash FlowOCF − Capex
$-14.1M
$28.5M
FCF MarginFCF / Revenue
-24.6%
33.5%
Capex IntensityCapex / Revenue
1.3%
0.1%
Cash ConversionOCF / Net Profit
-6.41×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-4.7M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AOUT
AOUT
FDMT
FDMT
Q4 25
$-13.3M
$28.6M
Q3 25
$-1.7M
$-46.5M
Q2 25
$7.8M
$-43.4M
Q1 25
$5.9M
$-47.8M
Q4 24
$-7.9M
$-134.6M
Q3 24
$-4.4M
$-29.4M
Q2 24
$14.7M
$-30.2M
Q1 24
$13.0M
$-29.1M
Free Cash Flow
AOUT
AOUT
FDMT
FDMT
Q4 25
$-14.1M
$28.5M
Q3 25
$-2.0M
$-46.6M
Q2 25
$7.2M
$-43.4M
Q1 25
$4.2M
$-48.4M
Q4 24
$-8.0M
$-138.4M
Q3 24
$-5.2M
$-31.2M
Q2 24
$14.2M
$-30.6M
Q1 24
$9.7M
$-29.8M
FCF Margin
AOUT
AOUT
FDMT
FDMT
Q4 25
-24.6%
33.5%
Q3 25
-6.7%
-51765.6%
Q2 25
11.6%
-289620.0%
Q1 25
7.2%
-345635.7%
Q4 24
-13.3%
-13837100.0%
Q3 24
-12.5%
-1038966.7%
Q2 24
30.6%
-611840.0%
Q1 24
18.2%
-106421.4%
Capex Intensity
AOUT
AOUT
FDMT
FDMT
Q4 25
1.3%
0.1%
Q3 25
1.0%
101.1%
Q2 25
0.9%
440.0%
Q1 25
2.9%
4507.1%
Q4 24
0.1%
378600.0%
Q3 24
2.0%
59266.7%
Q2 24
1.1%
6980.0%
Q1 24
6.2%
2535.7%
Cash Conversion
AOUT
AOUT
FDMT
FDMT
Q4 25
-6.41×
1.47×
Q3 25
Q2 25
Q1 25
34.86×
Q4 24
-2.55×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AOUT
AOUT

Traditional Channels Net Sales$36.8M64%
E Commerce Channels Net Sales$20.4M36%

FDMT
FDMT

Segment breakdown not available.

Related Comparisons